Tg Therapeutics (TGTX) Inventory Average (2023 - 2026)

Tg Therapeutics' Inventory Average history runs 4 years deep, the most recent figure standing at $127.3 million for Q1 2026.

• In Q1 2026, Inventory Average fell 5.07% year-over-year to $127.3 million; the TTM figure through Mar 2026 stood at $127.3 million (down 5.07% YoY), while the FY2025 annual figure was $118.0 million, up 57.07% from the prior year.
• Inventory Average for Q1 2026 stood at $127.3 million, down from $136.3 million in the prior quarter.
• The five-year high for Inventory Average was $156.5 million in Q2 2025, with the low at $28.7 million in Q2 2023.
• The 4-year median for Inventory Average is $90.3 million (2024), against an average of $93.4 million.
• The sharpest annual moves came in 2024 and 2026: Inventory Average jumped 176.67% in 2024, then declined 5.07% in 2026.
• Tg Therapeutics' Inventory Average stood at $36.7 million in 2023, then surged by 165.93% to $97.6 million in 2024, then soared by 39.67% to $136.3 million in 2025, then fell by 6.58% to $127.3 million in 2026.
• Business Quant data shows TGTX's Inventory Average at $127.3 million in Q1 2026, $136.3 million in Q4 2025, and $151.1 million in Q3 2025.